Erratum to: Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary | Zendy

AI Assistant Blog Pricing

Erratum to: Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.